Essex Investment Management CO LLC Moderna, Inc. Transaction History

Essex Investment Management CO LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$126.46 - $235.05 $923,158 - $1.72 Million	-7,300 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$225.82 - $368.51 $858,116 - $1.4 Million	-3,800 Reduced 34.23%	7,300 $1.85 Million
Q3 2021 Nov 09, 2021	SELL	$221.9 - $484.47 $865,410 - $1.89 Million	-3,900 Reduced 26.0%	11,100 $4.27 Million
Q1 2021 May 12, 2021	SELL	$109.18 - $185.98 $683,685 - $1.16 Million	-6,262 Reduced 29.45%	15,000 $1.96 Million
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $871,843 - $2.25 Million	13,262 Added 165.78%	21,262 $2.22 Million
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $434,720 - $758,800	8,000 New	8,000 $566,000
Q3 2019 Oct 22, 2019	SELL	$12.26 - $18.07 $275,543 - $406,123	-22,475 Closed	0 $0
Q2 2019 Aug 15, 2019	SELL	$13.7 - $28.34 $86,803 - $179,562	-6,336 Reduced 21.99%	22,475 $329,000
Q1 2019 May 15, 2019	BUY	$14.45 - $23.7 $278,307 - $456,462	19,260 Added 201.65%	28,811 $586,000
Q4 2018 Feb 06, 2019	BUY	$13.52 - $18.8 $129,129 - $179,558	9,551 New	9,551 $146,000

953

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Essex Investment Management CO LLC with notifications on news.